全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 2765082-12-8 | RMC-7977;(1S,5R)-N-[(7S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl]-21-ethyl-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-3-oxabicyclo[3.1.0]hexane-6-carboxamide | C47H60N8O6S |
| 2765413-92-9 | 3-Bromo-5-fluoro-4-iodo-2-methyl-aniline | C7H6BrFIN |
| 2765413-93-0 | 4-Bromo-6-fluoro-5-iodo-1H-indazole | C7H3BrFIN2 |
| 2765413-94-1 | 4-Bromo-6-fluoro-5-iodo-1-tetrahydropyran-2-YL-indazole | C12H11BrFIN2O |
| 2770278-13-0 | 4-Trifluorophenylethylammonium iodide;2-(4-(Trifluoromethyl)phenyl) ethan-1-aminium Iodide (TFPEAI) | C9H11F3IN |
| 2785346-75-8 | N-Pyrrolidino etonitazene;2-[(4-ethoxyphenyl)methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)benzimidazole | C22H26N4O3 |
| 2803372-49-6 | Edoxaban N-Oxide Impurity 2;5-Chloro-2-(2-(((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)amino)-2-oxoacetamido)pyridine 1-oxide | C24H30ClN7O5S |
| 2814500-04-2 | (4-(3,6-Diphenyl-9H-carbazol-9-yl)butyl)phosphonic acid;Ph-4PACz | C28H26NO3P |
| 2816821-08-4 | N-(diphenylmethylene)-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-((triisopropylsilyl)ethynyl)naphthalen-2-amine;N-[6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-[2-tri(propan-2-yl)silylethynyl]naphthalen-2-yl]-1,1-diphenylmethanimine | C40H47BFNO2Si |
| 2820536-99-8 | [(8S)-6-methylene-2,3,5,7-tetrahydro-1H-pyrrolizin-8-yl]methanol | C9H15NO |
| 2836267-80-0 | 5,7-Dichloro-8-fluoro-1H-pyrido[4,3-D]pyrimidine-2,4-dione | C7H2Cl2FN3O2 |
| 2865162-09-8 | Benzyl (S)-4-(5-(5-bromo-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-1H-indol-2-YL)-6-(1-methoxyethyl)pyridin-3-YL)piperazine-1-carboxylate;benzyl 4-[5-[5-bromo-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)indol-2-yl]-6-[(1S)-1-methoxyethyl]pyridin-3-yl]piperazine-1-carboxylate | C35H43BrN4O4 |
| 2869954-34-5 | Werner syndrome RecQ helicase-IN-1;HRO761; N-[2-chloro-4-(trifluoromethyl)phenyl]-2-[2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-[4-(5-hydroxy-6-methylpyrimidine-4-carbonyl)piperazin-1-yl]-7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4-yl]acetamide | C31H31ClF3N9O5 |
| 2875067-31-3 | (R)-4,4,4-Trifluoro-3-hydroxy-3-methylbutan-2-one;(3R)-4,4,4-trifluoro-3-hydroxy-3-methylbutan-2-one | C5H7F3O2 |
| 2915356-76-0 | Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH;Tirzepatide sidechain | C66H105N5O16 |
| 2922526-56-3 | (4-(3,6-Dimethoxy-9h-carbazol-9-yl)butyl)phosphonic acid;MeO-4PACz | C18H22NO5P |
| 2922732-54-3 | RMC-9805;KRAS G12D inhibitor 18; (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(6S,8S,14S)-21-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]acetamide | C63H88F3N11O7 |
| 2937344-16-4 | BI-2493;KRAS INHIBITOR; (7S)-2'-amino-3-[2-[(2S)-2-methylpiperazin-1-yl]pyrimidin-4-yl]spiro[5,6-dihydro-4H-1,2-benzoxazole-7,4'-6,7-dihydro-5H-1-benzothiophene]-3'-carbonitrile; (S)-2-amino-3'-(2-((S)-2-methylpiperazin-1-yl)pyrimidin-4-yl)-5',6,6',7-tetrahydro-4'H,5H-spiro[benzo[b]thiophene-4,7'-benzo[d]isoxazole]-3-carbonitrile | C24H27N7OS |
| 2971088-37-4 | (4-(2,7-Dibromo-9,9-dimethylacridin-10(9H)-yl)butyl)phosphonic acid | C19H22Br2NO3P |